Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1995
10/19/1995WO1995024481A3 Humanized monoclonal antibodies against human interleukin-4
10/19/1995WO1995020658A3 Diagnosis and treatment of infections due to streptococci and enterococci
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2187360A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
10/19/1995CA2187336A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995CA2187299A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995CA2187031A1 Immunodeficiency recombinant poxvirus
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995CA2164729A1 Catalase-based anti-helicobacter pylori immunising composition
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
10/18/1995EP0677532A1 Use of Il-1-antagonists as medicaments for treating diseases with increased Interleukin-6 serum levels
10/18/1995EP0677295A1 Liposome having oligosaccharide on the surface
10/18/1995EP0677114A1 Recombinant swinepox virus
10/18/1995EP0677106A1 Leukocyte derived growth factors
10/18/1995EP0677105A1 Allergenic proteins and peptides from dog dander and uses therefor
10/18/1995EP0677101A1 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof
10/18/1995EP0677057A1 Biopolymer synthesis utilizing surface activated, organic polymers
10/18/1995EP0676966A1 Antibodies directed against binding-associated epitopes
10/18/1995EP0676965A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds
10/18/1995EP0676964A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995EP0676954A1 Human immunodeficiency virus decoy
10/18/1995EP0576478B1 Herpes simplex vaccine comprising hsv glycoprotein gd and 3 deacylated monophosphoryl lipid a
10/18/1995EP0515415B1 Novel vaccine and method therefor
10/18/1995EP0485463B1 Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110280A Targeted forms of methyltrithio antitumor agents
10/18/1995CN1110177A Materials and methods for immunocontraception
10/18/1995CN1030086C Method for preparation of propolis bacterin for curing avian cholera
10/17/1995US5459238 Stimulate cytototoxic T lymphocyte immunity by interacting with human leucocyte antigen; possible AIDS vaccine
10/17/1995US5459235 Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
10/17/1995US5459073 Method and composition for preserving antigens and process for utilizing cytological material produced by same
10/17/1995US5459060 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
10/17/1995US5459048 DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995CA1337333C Legionellosis vaccines and methods for their production
10/17/1995CA1337332C Influenza vaccine and novel adjuvants
10/17/1995CA1337331C Intranasal vaccination of horses with inactivated micro-organisms or antigenic material
10/12/1995WO1995027069A1 Alphavirus rna as carrier for vaccines
10/12/1995WO1995027062A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027058A1 MOLECULAR CLONING AND EXPRESSION OF A η-INTERFERON INDUCIBLE ACTIVATOR OF THE PROTEASOME
10/12/1995WO1995027056A1 Parasite immunoglobulin binding proteins, and their use as vaccines
10/12/1995WO1995027045A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995027042A1 Genetically modified cells for use in transplantation
10/12/1995WO1995026986A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995WO1995026982A2 Malaria peptides
10/12/1995WO1995026980A2 Haptenated peptides and uses thereof
10/12/1995WO1995026979A1 Cytotoxic t-cell lymphocyte ('ctl') activity regulation by class i mhc peptides
10/12/1995WO1995026751A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026742A1 Immunotherapeutic agent and its use
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
10/12/1995WO1995024923A3 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
10/12/1995WO1995009232A3 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof
10/12/1995CA2187200A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995CA2187193A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides
10/12/1995CA2186913A1 Compositions and methods for delivery of genetic material
10/12/1995CA2186873A1 Haptenated peptides and uses thereof
10/12/1995CA2186859A1 Molecular cloning and expression of a .gamma.-interferon inducible activator of the proteasome
10/12/1995CA2186857A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995CA2186528A1 Genetically modified cells for use in transplantation
10/12/1995CA2186469A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995CA2185211A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/11/1995EP0676467A2 European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
10/11/1995EP0676413A2 Interferon-alpha/beta binding protein, its preparation and use
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675957A1 Vaccines against varicella-zoster virus (vzv)
10/11/1995EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
10/11/1995EP0675903A1 Bone resorption assay
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675734A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT
10/11/1995EP0675733A1 Peptide-carbohydrate conjugates generating t-cell immunity
10/11/1995EP0675729A1 ACTIVATION OF p53 PROTEIN
10/11/1995EP0460167B1 Humanised antibodies
10/11/1995EP0457814B1 Increased protein production in animals
10/11/1995EP0397700B1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
10/11/1995CN1109886A Method for preparing thioether conjugates
10/11/1995CN1109784A Hepatitis B surface antigen protein having ammonia end with pre-surface antigen determinant
10/11/1995CN1109783A Oral hydrophobia vaccine for dog and productive process thereof
10/11/1995CN1109782A Production of inactivated vaccine for epidemic hemorrhagic fever using primary cells of kidney of golden yellow hamster
10/11/1995CN1109763A Vaccinal efficacy augmentor and efficacy-augmenting foods
10/10/1995US5457038 Natural killer stimulatory factor
10/10/1995US5456924 Method of treatment of HIV-seropositive individuals with dietary whey proteins
10/10/1995US5456914 Administering antigen by injection directly into lung of animal, producing high levels of antibodies against lung pathogen
10/10/1995US5456911 Immunogen where peptides are crosslinked by treatment with glutaraldehyde
10/10/1995CA1337278C Activated rnase l as a marker for viral infections
10/10/1995CA1337277C Rnase l inhibitor as a marker for virus infections
10/10/1995CA1337269C Vaccine against brucella abortus
10/10/1995CA1337268C Canine distemper virus vaccine
10/10/1995CA1337267C Canine coronavirus vaccine
10/10/1995CA1337266C Virus and vaccine therefrom for use against turkey rhinotracheitis
10/10/1995CA1337265C Oral antibody therapy for patients with lowered immune response and composition therefor
10/05/1995WO1995026507A1 Differential expansion of fetal stem cells in the maternal circulation for use in prenatal genetic analysis
10/05/1995WO1995026405A1 T-lymphotropic primate virus l (ptlv-l) and its applications
1 ... 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 ... 1823